
About Bio-Techne India Private Limited
Data last updated:
Bio-Techne India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Bio-Techne Corporation. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 08 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017FTC302647. Its GSTIN is 27AAHCB5571F1ZM (Maharashtra).
The company has an authorised share capital of ₹1.98 Cr and a paid-up capital of ₹1.98 Cr. It is led by directors including Anand Khetan and Shane Victor Bohnen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 707 Lodha Supremus Senapati Bapat Marg Nr. Hdfc Bank House Lower Parel West, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.35 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹70.53 Lakh (net margin 9.6%) and EBITDA of ₹1.1 Cr (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 28% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bio-Techne. As per MCA filings, the company has open charges of ₹50,000 on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bio-techne.com.
Company details
Contact details
Bio-Techne India Private Limited's registered office is in Mumbai, Maharashtra. Its website is bio-techne.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address707 Lodha Supremus Senapati Bapat Marg Nr. Hdfc Bank House Lower Parel West, Mumbai, Maharashtra, India – 400013
- IndustryLife Sciences, Biotechnology
To see the full contact details of Bio-Techne India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bio-Techne India operates one associated brand: Bio-Techne. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of biotech reagents, instruments and clinical diagnostic products | bio-techne.com |
Business activity
The main business activity of Bio-Techne India is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Bio-Techne India Private Limited, buy the company report.
Financials of Bio-Techne India Private Limited
FY 2025 filings availableBio-Techne India Private Limited reported revenue of ₹7.35 Cr (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 9% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | ||||
| Net Profit Margin | 9.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bio-Techne India Private Limited, buy the company report.
Board of directors of Bio-Techne India Private Limited
Bio-Techne India has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Khetan | Director | 14 Mar 2019 | 7 Years 7 Months | Current |
| Shane Victor Bohnen | Director | 08 Sep 2023 | 3 Years 2 Months | Current |
| James Todd Hippel | Director | 08 Dec 2017 | 8 Years 11 Months | Current |
Auditor
Bio-Techne India Private Limited is audited by V S N & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V S N & CO. | FY 2023 | 156100W |
Shareholding
The shareholding of Bio-Techne India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bio-Techne India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2020 | 100382638 | Others | ₹50,000 | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Bio-Techne India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Bio-Techne India Private Limited has 5 MSME Form 1 returns on record between 2021 and 2023, listing 5 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Roedl & Partner Consulting Private Limited |
To see the full MSME payment records of Bio-Techne India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bio-Techne India Private Limited has a workforce of 10 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Bio-Techne India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCB5571F1ZM | Maharashtra | Active | 09 May 2018 |
To see the full GST registrations and return filing status of Bio-Techne India Private Limited, buy the company report.
Recent activity
Bio-Techne India Private Limited has 7 board changes on record since 2017: 3 appointments and 4 cessations. The latest: Brenda Swierenga Furlow ceased to be Director on 22 Nov 2023.
News
Frequently asked questions
Bio-Techne India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 08 December 2017 (9+ years old) and is registered under CIN U51909MH2017FTC302647.
Bio-Techne India has 3 current directors:
- Anand Khetan - Director
- Shane Victor Bohnen - Director
- James Todd Hippel - Director
The latest financial statements of Bio-Techne India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Bio-Techne India is 27AAHCB5571F1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bio-Techne India is U51909MH2017FTC302647. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bio-Techne India was incorporated on 08 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Brenda Swierenga Furlow ceased to be Director on 22 Nov 2023. Shane Victor Bohnen ceased to be Additional Director on 29 Sep 2023. Shane Victor Bohnen was appointed as Director on 08 Sep 2023. Bio-Techne India has 7 board changes on record in total.
Bio-Techne India has 5 MSME Form 1 returns on record between 2021 and 2023, listing 5 overdue payments to 1 micro and small supplier. The latest return was filed on 29 Aug 2023.
Bio-Techne India can be reached through the website bio-techne.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Bio-Techne India is at 707 Lodha Supremus Senapati Bapat Marg Nr. Hdfc Bank House Lower Parel West, Mumbai, Maharashtra, India – 400013.
Bio-Techne India operates in the life sciences industry, in the biotechnology segment.

